Am J Health Syst Pharm. 2006;63(10):929-938. The goal of sulfonylurea overdose management is the return of euglycemia, with either dextrose supplementation or reduction of insulin secretion.

A cryoEM structure of KATP bound to Aekatperone showed that the molecule binds at the ... were excluded. The identified molecules contain sulfonylurea-like moieties. How different are they from other ...

Through a comprehensive structure–activity relationship (SAR ... which has the potential to mitigate side effects and toxicities associated with conventional diaryl sulfonylurea-containing compounds.

It is made of dead, flattened cells called keratinocytes that are shed approximately two weeks after they enter this layer. Keratinocytes produce keratin, a fibrous protein that helps provide ...

How should this patient be managed? I would recommend discontinuing the SU (particularly as the patient is on a very small dose) and re-evaluating whether any therapy is required. If he or she ...